Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01HX003252-01 |
| Title: | Comparative Effectiveness and Safety of Newer and Older Antihyperglycemic Medications |
| Principal Investigator: | Ziyad AlAly |
| Location: | St Louis, MO |
| Congressional District Code: | 1 |
| Research Service: | Health Services R&D |
| Project Period: | July 2021 - June 2025 |
| FY 2021 Funding Amount: | $73,314 |
| Total Award Amount (all years): |
$1,172,997 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Background: People diagnosed with diabetes are initially advised on lifestyle changes and started on metformin, but often require the addition of 2nd line antihyperglycemic medications. The choice of 2nd line antihyperglycemic therapy is complex because the multiple available drugs, distributed across several drug classes, have different benefits and risks. Newer 2nd line antihyperglycemics (sodium-glucose co-transporter-2 inhibitor (SGLT2i), and glucagon-like peptide-1 receptor agonist (GLP1))... |